Community-Acquired Pneumonia and Acid-Suppressive Drugs: Position Statement

Community-Acquired Pneumonia and Acid-Suppressive Drugs: Position Statement

Saved in:

Bibliographic Details
Main Author:	CAG Clinical Affairs Committee
Format:	Article
Language:	English
Published:	Wiley 2006-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2006/324976
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Canadian Association of Gastroenterology Position Statement: Hip Fracture and Proton Pump Inhibitor Therapy – a 2013 Update
by: Paul Moayyedi, et al.
Published: (2013-01-01)

Propofol Use for Sedation during Endoscopy in Adults: A Canadian Association of Gastroenterology Position Statement
by: Michael F Byrne, et al.
Published: (2008-01-01)

Pneumonia acquired in the Community
by: María Caridad Fragoso Marchante, et al.
Published: (2007-06-01)

Epidemiology of Community-Acquired Pneumonia
by: Thomas J Marrie
Published: (1998-01-01)

Frequency of viral etiology in community-acquired pneumonia
by: Zain Ahmad Khan, et al.
Published: (2025-01-01)

Interim Report on Drug Utilization Review of Community Acquired, Nursing Home Acquired and Nosocomial Pneumonia: Clinical, Bacteriological and Radiological Spectrum
by: CW Chow, et al.
Published: (1994-01-01)

Community acquired pneumonia: Rampant Empiricism or Cautious Overkill?
by: LE Nicolle
Published: (1993-01-01)

Private Costs of Patients Hospitalized with Community-Acquired Pneumonia
by: Philip Jacobs, et al.
Published: (2005-01-01)

Acquired severe pneumonia in the community in seropositive HIV patients.
by: Héctor Cruz de los Santos, et al.
Published: (2004-12-01)

Trend of Use of Quinolone Antibiotics in Community-Acquired Pneumonia
by: Kadir Burak AKGÜN, et al.
Published: (2025-01-01)

COMMUNITY-ACQUIRED PNEUMONIA COMPLICATED BY SEPSIS CAUSED BY KLEBSIELLA PNEUMONIAE: A CASE REPORT
by: A.V. Lavrenko
Published: (2017-12-01)

Analysis of Lymphocyte Subpopulations and Cytokines in COVID-19-Associated Pneumonia and Community-Acquired Pneumonia
by: Guohong Liu, et al.
Published: (2021-01-01)

Appearances Can Be Deceiving: What Is the Diagnosis for this Community-Acquired Pneumonia?
by: Frank YH Lin, et al.
Published: (2001-01-01)

Community-Acquired Pneumonia in Children: A Multidisciplinary Consensus Review
by: Donald E Low, et al.
Published: (2003-01-01)

The effect of immunosuppression on outcomes in elderly patients with community-acquired pneumonia
by: Lixue Huang, et al.
Published: (2025-01-01)

Predictors of severe community-acquired pneumonia associated with coronavirus infection
by: S. S. Avhaitis
Published: (2024-12-01)

Etiology of Community Acquired Pneumonia at a Tertiary Care Hospital
by: Ritika Jha, et al.
Published: (2024-06-01)

Community Acquired, Nursing Home Acquired and Hospital Acquired Pneumonia: A Five-Year Review of the Clinical, Bacteriological and Radiological Characteristics
by: CW Chow, et al.
Published: (1995-01-01)

Factors Associated with Length of Stay in Hospital for Suspected Community-Acquired Pneumonia
by: Jane Q Huang, et al.
Published: (2006-01-01)

Antimicrobial Treatment of Community Acquired Pneumonia in Adults: A Conference Report
by: The Canadian Community Acquired Pneumonia Consensus Conference Group
Published: (1994-01-01)

Community-Acquired Pneumonia Requiring Hospitalization among French Guianese Children
by: Alexandre Cannesson, et al.
Published: (2021-01-01)

Community-Acquired Pneumonia and Empyema Caused by Citrobacter koseri in an Immunocompetent Patient
by: Miguel Angel Ariza-Prota, et al.
Published: (2015-01-01)

Applying an Instrument for the Stratification of Patients with Community-acquired Pneumonia in the Emergency Department.
by: Luis Alberto Corona Martínez, et al.
Published: (2011-10-01)

Fulfilment assessment of the good clinical practices guidelines for community acquired pneumonia.
by: Iris Gonzalez Morales, et al.
Published: (2009-07-01)

Impact of order set implementation on appropriate treatment of community-acquired pneumonia (CAP)
by: Han Pham, et al.
Published: (2025-01-01)

Clinical Characteristics and Microorganisms Isolated in Community-Acquired Pneumonia in the COVID-19 Period
by: Meritxell Gavalda, et al.
Published: (2024-01-01)

Epidemiology of Community-Acquired Pneumonia in Edmonton, Alberta: An Emergency Department-Based Study
by: Thomas J Marrie, et al.
Published: (2005-01-01)

The role of the neutrophil-to-lymphocyte ratio in predicting outcomes among patients with community-acquired pneumonia
by: Yogesh Sharma, et al.
Published: (2025-01-01)

Neutrophil Oxidized-Modified Proteins and Neutrophil Extracellular Traps in Patients with Community-Acquired Pneumonia
by: Vilen Molotov-Luchanskiy, et al.
Published: (2020-01-01)

ESTIMATION OF USING MEDICATIONS OF DIFFERENT GROUPS FOR COMMUNITY-ACQUIRED PNEUMONIA TREATMENT OF PATIENTS WITH COMORBIDITIES
by: A.V. Demchuk
Published: (2017-03-01)

Corrigendum to “Community-Acquired Cavitary Pseudomonas Pneumonia Linked to Use of a Home Humidifier”
by: Eric C. Woods, et al.
Published: (2018-01-01)

The Role of Red Blood Cell Distribution Width in the Severity and Prognosis of Community-Acquired Pneumonia
by: Qiang Ren, et al.
Published: (2021-01-01)

Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease
by: Helen C. Steel, et al.
Published: (2013-01-01)

Proteomic, metabolomic and lipidomic profiles in community acquired pneumonia for differentiating viral and bacterial infections
by: Samuel Rischke, et al.
Published: (2025-01-01)

Appraisal of the risk index as instrument to the stratification of the patient with acquired pneumonia in the community in the emergency department.
by: Dianelis Sierra Martínez, et al.
Published: (2005-08-01)

Adherence to clinical practice guidelines on community acquired pneumonia and its relation to mortality rates.
by: María Caridad Fragoso Marchante, et al.
Published: (2010-08-01)

Serum Vitamin D Level and Risk of Community-Acquired Pneumonia: A Case-Control Study
by: Guwani Liyanage, et al.
Published: (2021-01-01)

How Nova Scotia General Practitioners Choose Antibiotics for the Empirical Treatment of Community-Acquired Pneumonia
by: Jacob Pendergrast, et al.
Published: (2000-01-01)

Population-Based Surveillance for Hypermucoviscosity Klebsiella pneumoniae Causing Community-Acquired Bacteremia in Calgary, Alberta
by: Gisele Peirano, et al.
Published: (2013-01-01)

Characteristics, Management, and Outcomes of Community-Acquired Pneumonia Due to Human Rhinovirus—A Retrospective Study
by: Ibrahim Bahabri, et al.
Published: (2022-01-01)